BioCentury
ARTICLE | Company News

Cognosci, Oncotide deal

April 11, 2011 7:00 AM UTC

Cognosci spun-out newco Oncotide to discover and develop protein phosphatase modulators to treat cancer. Cognosci granted Oncotide an exclusive license for IP covering its cancer pipeline, and provide...